{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:07:39Z","timestamp":1789049259451,"version":"build-2803163510"},"reference-count":26,"publisher":"Scientific Scholar","issue":"2&3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2]]},"abstract":"\n Background & objectives:<\/jats:title>\n Vaccines play a crucial role in the prevention of tuberculosis (TB). Revaccination with Bacille Calmette\u2013Guerin (BCG) for the prevention of TB is an important strategy that is currently gaining interest. The objective of this study was to reanalyze the community-based Chingleput BCG vaccination trial for protective efficacy of BCG revaccination against incident TB disease.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n A retrospective analysis of the Chingleput BCG vaccination trial (conducted in 1968) data was carried out. Data on participants with evidence of prior BCG vaccination at trial intake and randomized to BCG vaccine [low dose (0.01 mg), high dose (0.1 mg)] and placebo arms were analyzed. The incidence of TB disease, which was based on sputum culture and\/or chest X-ray was compared between the BCG and placebo arms over a 15 yr follow up period.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n Of the 269,727 individuals randomized in the trial; 263,158 had no evidence of TB at baseline, of which 4436 (1.68%) had evidence of BCG vaccination at trial intake (2890 in the BCG vaccine and 1546 in the placebo arms, respectively). There were 77 (190 per 100,000) and 64 (296 per 100,000) incident TB cases in the BCG and placebo arm, respectively, at 15 yr post-vaccination. The incidence of TB disease was significantly lower in the BCG arm [Hazard ratio of BCG arm (95% confidence interval): 0.64 (0.46-0.89)].<\/jats:p>\n <\/jats:sec>\n \n Interpretation & conclusions:<\/jats:title>\n Retrospective data analysis of this community-based trial revealed that BCG revaccination in a community offered modest protection against the development of TB disease at the end of 15 years which, however, requires further evaluation.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_1540_22","type":"journal-article","created":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T11:17:58Z","timestamp":1663499878000},"page":"152-159","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["Revisiting the Chingleput BCG vaccination trial for the impact of BCG revaccination on the incidence of tuberculosis disease"],"prefix":"10.25259","volume":"157","author":[{"given":"Banurekha","family":"Velayutham","sequence":"first","affiliation":[{"name":"Department of Clinical Research, ICMR- National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kannan","family":"Thiruvengadam","sequence":"additional","affiliation":[{"name":"Statistics Section, Epidemiology Unit, ICMR- National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paramasivam Paul","family":"Kumaran","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, ICMR- National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basilea","family":"Watson","sequence":"additional","affiliation":[{"name":"Statistics Section, Epidemiology Unit, ICMR- National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnan","family":"Rajendran","sequence":"additional","affiliation":[{"name":"Statistics Section, Epidemiology Unit, ICMR- National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrasekaran","family":"Padmapriyadarsini","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, ICMR- National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2023,5,3]]},"reference":[{"key":"R2-20241212","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.3389\/fmicb.2019.03154","article-title":"Clinical development of new TB vaccines:Recent advances and next steps","volume":"10","author":"Hatherill","year":"2020","journal-title":"Front Microbiol"},{"key":"R3-20241212","first-page":"56","article-title":"Fifteen year follow up of trial of BCG vaccines in south India for tuberculosis prevention","volume":"110","year":"1999","journal-title":"Indian J Med Res"},{"key":"R4-20241212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17370","article-title":"Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Gu\u00e9rin vaccination against tuberculosis","volume":"17","author":"Abubakar","year":"2013","journal-title":"Health Technol Assess"},{"key":"R5-20241212","doi-asserted-by":"crossref","first-page":"e1451","DOI":"10.1016\/S2214-109X(21)00309-0","article-title":"BCG re-vaccination in Malawi:30-year follow-up of a large, randomised, double-blind, placebo-controlled trial","volume":"9","author":"Glynn","year":"2021","journal-title":"Lancet Glob Health"},{"key":"R6-20241212","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1016\/j.vaccine.2011.05.023","article-title":"Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil:Second report of the BCG-REVAC cluster-randomised trial","volume":"29","author":"Barreto","year":"2011","journal-title":"Vaccine"},{"key":"R7-20241212","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1714021","article-title":"Prevention of M. tuberculosis infection with H4: IC31 vaccine or BCG revaccination","volume":"379","author":"Nemes","year":"2018","journal-title":"N Engl J Med"},{"key":"R8-20241212","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1164\/ajrccm.157.4.9706037","article-title":"Bacillus Calmette-Gu\u00e9rin revaccination questionable with low tuberculosis incidence","volume":"157","author":"Tala-Heikkil\u00e4","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"R9-20241212","first-page":"717","article-title":"Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong","volume":"5","author":"Leung","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"key":"R10-20241212","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1080\/00365540701367777","article-title":"Primary vaccination and revaccination of young adults with BCG:A study using immunological markers","volume":"39","author":"Fj\u00e4llbrant","year":"2007","journal-title":"Scand J Infect Dis"},{"key":"R11-20241212","doi-asserted-by":"crossref","first-page":"130540","DOI":"10.1172\/jci.insight.130540","article-title":"BCG revaccination boosts adaptive polyfunctional Th1\/Th17 and innate effectors in IGRA+and IGRA- Indian adults","volume":"4","author":"Rakshit","year":"2019","journal-title":"JCI Insight"},{"issue":"Suppl","key":"R12-20241212","first-page":"1","volume":"72","year":"1980","journal-title":"Indian J Med Res"},{"key":"R13-20241212","first-page":"656","article-title":"Bacille Calmette-Guerin (BCG) revaccination:Is it beneficial for tuberculosis control?","volume":"2","author":"Ahmad","year":"2013","journal-title":"Sci Rep"},{"key":"R14-20241212","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1172\/JCI133935","article-title":"BCG vaccination in humans inhibits systemic inflammation in a sex-dependent manner","volume":"130","author":"Koeken","year":"2020","journal-title":"J Clin Invest"},{"key":"R15-20241212","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/infdis\/jix612","article-title":"Rapid protective effects of early BCG on neonatal mortality among low birth weight boys:Observations from randomized trials","volume":"217","author":"Biering-S\u00f8rensen","year":"2018","journal-title":"J Infect Dis"},{"key":"R16-20241212","doi-asserted-by":"crossref","first-page":"7253","DOI":"10.1016\/j.vaccine.2021.09.039","article-title":"Weaker protection against tuberculosis in BCG-vaccinated male 129 S2 mice compared to females","volume":"39","author":"Nieuwenhuizen","year":"2021","journal-title":"Vaccine"},{"key":"R17-20241212","doi-asserted-by":"crossref","first-page":"e1002119","DOI":"10.1371\/journal.pmed.1002119","article-title":"Sex differences in tuberculosis burden and notifications in low- and middle-income countries:a systematic review and metanalysis","volume":"13","author":"Horton","year":"2016","journal-title":"PLoS Med"},{"key":"R18-20241212","doi-asserted-by":"crossref","first-page":"100313","DOI":"10.1016\/j.eclinm.2020.100313","article-title":"A phase 1b randomized study of the safety and immunological responses to vaccination with H4:IC31, H56:IC31, and BCG revaccination in Mycobacterium tuberculosis-uninfected adolescents in Cape Town, South Africa","volume":"21","author":"Bekker","year":"2020","journal-title":"EClinicalMed"},{"key":"R19-20241212","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3389\/fimmu.2017.01134","article-title":"What have we learnt about BCG vaccination in the last 20 years?","volume":"8","author":"Dockrell","year":"2017","journal-title":"Front Immunol"},{"key":"R20-20241212","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis:A systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R21-20241212","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1016\/j.vaccine.2020.08.016","article-title":"The safety of BCG revaccination:A systematic review","volume":"39","author":"Bannister","year":"2021","journal-title":"Vaccine"},{"key":"R22-20241212","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41541-021-00421-5","article-title":"Revaccination with Bacille Calmette-Gu\u00e9rin (BCG) is associated with an increased risk of abscess and lymphadenopathy","volume":"7","author":"Villanueva","year":"2022","journal-title":"NPJ Vaccines"},{"key":"R23-20241212","doi-asserted-by":"crossref","first-page":"632478","DOI":"10.3389\/fimmu.2021.632478","article-title":"The BCG vaccine for COVID-19:First verdict and future directions","volume":"12","author":"Gonzalez-Perez","year":"2021","journal-title":"Front Immunol"},{"key":"R24-20241212","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cell.2020.08.051","article-title":"Activate:Randomized clinical trial of BCG vaccination against infection in the elderly","volume":"183","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell"},{"key":"R25-20241212","doi-asserted-by":"crossref","first-page":"100073","DOI":"10.1016\/j.xcrm.2020.100073","article-title":"Safety and COVID-19 symptoms in individuals recently vaccinated with BCG:A retrospective cohort study","volume":"1","author":"Moorlag","year":"2020","journal-title":"Cell Rep Med"},{"key":"R26-20241212","doi-asserted-by":"crossref","first-page":"eabg7181","DOI":"10.1126\/sciadv.abg7181","article-title":"Effect of BCG vaccination on proinflammatory responses in elderly individuals","volume":"7","author":"Pavan","year":"2021","journal-title":"Sci Adv"},{"key":"R27-20241212","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijid.2021.07.041","article-title":"BCG vaccination induces enhanced frequencies of dendritic cells and altered plasma levels of type I and type III interferons in elderly individuals","volume":"110","author":"Kumar","year":"2021","journal-title":"Int J Infect Dis"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/ijmr.ijmr_1540_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T19:06:12Z","timestamp":1751483172000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/revisiting-the-chingleput-bcg-vaccination-trial-for-the-impact-of-bcg-revaccination-on-the-incidence-of-tuberculosis-disease\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":26,"journal-issue":{"issue":"2&3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_1540_22","relation":{},"ISSN":["0971-5916","0975-9174"],"issn-type":[{"value":"0971-5916","type":"print"},{"value":"0975-9174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"2022-07-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}